ADP-A2M4CD8 as Monotherapy or in Combination With Either Nivolumab or Pembrolizumab in HLA-A2+ Subjects With MAGE-A4 Positive Tumors (SURPASS)
USWM, LLC (dba US WorldMeds)
USWM, LLC (dba US WorldMeds)
Seagen Inc.
Conjupro Biotherapeutics, Inc.
AstraZeneca
Dragonfly Therapeutics
Ensem Therapeutics
PMV Pharmaceuticals, Inc
Hoffmann-La Roche
Eli Lilly and Company
ViroMissile, Inc.
Tizona Therapeutics, Inc
IDEAYA Biosciences
Theravectys S.A.
xCures
Daiichi Sankyo
SN BioScience
Adela, Inc
Perspective Therapeutics
Natera, Inc.
Second Life Therapeutics
Elephas
Varian, a Siemens Healthineers Company
Novartis
Elephas
Varian, a Siemens Healthineers Company
I-Mab Biopharma US Limited
BicycleTx Limited
TScan Therapeutics, Inc.
TScan Therapeutics, Inc.
Bolt Biotherapeutics, Inc.
Shasqi, Inc.
Tempus AI
Massive Bio, Inc.
Actym Therapeutics, Inc.
LigaChem Biosciences, Inc.
Bolt Biotherapeutics, Inc.
Palleon Pharmaceuticals, Inc.
Exelixis
Bicara Therapeutics
Sensei Biotherapeutics, Inc.
Incyte Corporation
RefleXion Medical
A2 Biotherapeutics Inc.
Marengo Therapeutics, Inc.
Varian, a Siemens Healthineers Company
ModeX Therapeutics, An OPKO Health Company
Celldex Therapeutics
Tempus AI
Revolution Medicines, Inc.
Elevation Oncology